Company news

Genetic Technologies Limited news in 2022

Genetic Technologies Limited's news releases, calls and decks from 2022, newest first.

View company

GeneType Published in PLUS ONE for CVD & Type 2 Diabetes

December 5, 2022

AGM Presentation and Chairmans Address

November 27, 2022

Genetype for Ovarian Cancer published in European Journal

November 9, 2022

GeneType Outperforms Traditional Risk Assessments

September 28, 2022

GTG Building Momentum on Commercial Plans

August 30, 2022

Annual Report to Shareholders and Appendix 4E

August 30, 2022

Q4 FY22 Results Milestones and Growth

July 27, 2022

GeneType Risk Test Implemented in 9 Siles Health Clinics

July 17, 2022

Completion of AffinityDNA Acquisition

July 14, 2022

EasyDNA Expands Indian and European Markets

July 4, 2022

GeneType Risk Assessment Test Onboarding in 16 clinics

June 29, 2022

Transformational Pathway to US Payer System

June 16, 2022

Acquisition of Global Direct to Consumer Ecommerce Business

May 15, 2022

Genetic Technologies 1H FY22 results

February 23, 2022

Half Year Report and Accounts

February 23, 2022

US Patent Office Grants Patent for COVID-19 Risk Test

February 23, 2022

GeneType Multi-Test Approved for Commercial Release

February 20, 2022

Quarterly Activities Report & Appendix 4C

January 18, 2022

Decks in 2022